SEC Form 4 · accession 0000920465-19-000025
LA JOLLA PHARMACEUTICAL CO · LJPC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lakhmir S Chawla
Officer — Chief Medical Officer
Period of report
Jan 29, 2019
Accepted (ET)
Jan 31, 2019 · 6:49 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000920465
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 29, 2019 | P | 800 | $5.55 | A | 3,059 | D | |
| Common Stock | Jan 29, 2019 | P | 1,200 | $5.57 | A | 4,259 | D | |
| Common Stock | Jan 30, 2019 | P | 800 | $5.5699 | A | 5,059 | D | |
| Common Stock | Jan 30, 2019 | P | 200 | $5.57 | A | 5,259 | D |
Table II — derivative securities
No Table II lines on this filing.